The Veteran's melasma has been manifested by pigmentation changes on the face, covering less than 20% of her entire body and exposed areas. The disability does not meet the criteria for a higher rating as it does not affect more than 20% of her exposed areas or require systemic therapy such as corticosteroids.
The deciding factor: The Veteran's melasma did not cover at least 20% of her exposed areas, and she was not on systemic therapy requiring six weeks or more of corticosteroids or other immunosuppressive drugs during the past 12-month period.
- Claimed conditions
- melasma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- July 7, 2014
- Citation
- 1430398
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1430398.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has remanded the claims of service connection for ischemic heart disease, a skin disorder (melasma), and prostate cancer due to potential exposure to herbicide agents in Guam under the PACT Act.
- Remanded (sent back)
The Veteran's appeal is remanded due to inadequate medical examination and the need for a new one. The skin condition, including keratosis pilaris, folliculitis, and melasma, needs to be re-evaluated.
- Granted
The Board has granted service connection for endometriosis, hysterectomy as secondary to endometriosis, and melasma as secondary to endometriosis. The decision is based on the Veteran's credible testimony and medical opinions that link these conditions to her service-connected endometriosis.
- Remanded (sent back)
The Board has remanded the case due to new evidence received after the September 2020 Supplemental Statement of the Case. The claim for an evaluation in excess of 30 percent for keratosis pilaris, folliculitis, and melasma will be reconsidered.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.